# Taipei Veterans General Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/taipei-veterans-general-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 37.2 |
| Citations | 3,145,571 |
| City | Taipei |
| Country | TW |
| Description | Taipei Veterans General Hospital is a research organisation in Taipei, TW. OpenAlex records 36,373 works and 3,145,571 citations for it. 10,520 researchers list it as their most recent affiliation. |
| Homepage | http://www.vghtpe.gov.tw/ |
| OpenAlex ID | https://openalex.org/I2803004286 |
| Researchers | 10,520 |
| ROR ID | https://ror.org/03ymy8z76 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q11411924 |
| Works | 36,373 |

## University papers

Showing 12 of 43.

- [Erlotinib in Previously Treated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/erlotinib-in-previously-treated-non-small-cell-lung-cancer/)
- [Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-after-adjuvant-chemotherapy-in-her2-positive-breast-cancer/)
- [Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer](https://scholariq.org/papers/crizotinib-versus-chemotherapy-in-advanced-i-alk-i-positive-lung-cancer/)
- [Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations](https://scholariq.org/papers/phase-iii-study-of-afatinib-or-cisplatin-plus-pemetrexed-in-patients-with/)
- [Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-emtansine-for-residual-invasive-her2-positive-breast-cancer/)
- [Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials](https://scholariq.org/papers/afatinib-versus-cisplatin-based-chemotherapy-for-egfr-mutation-positive-lung/)
- [Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial](https://scholariq.org/papers/afatinib-versus-placebo-for-patients-with-advanced-metastatic-non-small-cell/)
- [Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis](https://scholariq.org/papers/impact-of-egfr-inhibitor-in-non-small-cell-lung-cancer-on-progression-free-and/)
- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast/)
- [Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study](https://scholariq.org/papers/overall-survival-improvement-in-patients-with-lung-cancer-and-bone-metastases/)
- [Stage Shift Improves Lung Cancer Survival: Real-World Evidence](https://scholariq.org/papers/stage-shift-improves-lung-cancer-survival-real-world-evidence/)
- [Infective endocarditis in children without underlying heart disease](https://scholariq.org/papers/infective-endocarditis-in-children-without-underlying-heart-disease/)

## University researchers

- [Yen‐Ting Lin](https://scholariq.org/researchers/yen-ting-lin/)
- [Chiu-Yang Lee](https://scholariq.org/researchers/chiu-yang-lee/)
- [Ching‐Wei Lin](https://scholariq.org/researchers/ching-wei-lin/)

## University top topics

Showing 8 of 25.

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.